Sign Up to like & get recommendations! 0
Published in 2019 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.12.003
Abstract: BACKGROUND TERT promoter mutations are associated with adverse clinicopathological characteristics in thyroid carcinomas and considered as a major indicator of poor outcomes. Nevertheless, most studies have pooled heterogeneous types of thyroid carcinomas and have been conducted… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Modern Pathology"
DOI: 10.1038/s41379-021-00776-z
Abstract: Telomerase reverse transcriptase (TERT) promoter mutations have been implicated in urothelial carcinogenesis and are present in 60–80% of conventional and variants of urothelial carcinomas. We investigated the prevalence of TERT promoter mutations in 46 cases… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-236702
Abstract: In this review, we summarise the function and structure of telomerase reverse transcriptase (TERT) in humans, including its regulation. The dysregulation of telomerase through TERT promoter mutations across a range of cancers is discussed. The… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Clinical Pathology"
DOI: 10.1136/jclinpath-2018-205132
Abstract: Aims Solitary fibrous tumour (SFT) is an infrequently metastasising mesenchymal tumour defined by the NAB2–STAT6 fusion gene. Activating mutations in the telomerase reverse transcriptase (hTERT) gene promoter has been reported to associate with adverse patient… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/6300329
Abstract: Malignant melanoma is an extremely malignant tumor with a high mortality rate and an increasing incidence with a high mutation load. The frequency of mutations in the TERT promoter exceeds the frequency of any known… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Clinical Investigation"
DOI: 10.1172/jci91161
Abstract: Germline coding mutations in different telomere-related genes have been linked to autosomal-dominant familial pulmonary fibrosis. Individuals with these inherited mutations demonstrate incomplete penetrance of clinical phenotypes affecting the lung, blood, liver, skin, and other organs.… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Clinical chemistry"
DOI: 10.1373/clinchem.2017.284257
Abstract: To the Editor: Droplet digital PCR (ddPCR) assays partition PCR reactions into multiple compartments. PCR amplification followed by analysis of end point fluorescence of each partition allows the absolute quantification of the target sequence. ddPCR… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10030728
Abstract: This article reviews the existing approaches to determining the TERT promoter mutational status in patients with various tumoral diseases of the central nervous system. The operational characteristics of the most common methods and their transferability… read more here.
Sign Up to like & get recommendations! 3
Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11030691
Abstract: Head and neck cancers (HNCs) are among the ten leading malignancies worldwide. Despite significant progress in all therapeutic modalities, predictive biomarkers, and targeted therapies for HNCs are limited and the survival rate is unsatisfactory. The… read more here.